Outi Sareila

Outi Sareila

Auto-generated profile, based on publicly available information

Outi Sareila

Department of Medical Biochemistry and Biophysics, Medical Inflammation Research Karolinska Institutet Stockholm Sweden

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2011 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
OSOuti Sareila
Outi Sareila
Tiina KelkkaTiina Kelkka
Tiina Kelkka
APAngela Pizzolla
Angela Pizzolla
MHMalin Hultqvist
Malin Hultqvist
Rikard HolmdahlRikard Holmdahl
Rikard Holmdahl
Reactive oxygen species (ROS) are a heterogeneous group of highly reactive molecules that oxidize targets in a biologic system. During steady-state conditions, ROS are constantly produced in the electron-transport chain during cellular respiration and by various constitutively active oxidases. ROS production can also be induced by activation of the phagocyte NADPH oxidase 2 (NOX2) complex in a process generally referred to as an oxidative burst. The induced ROS have long been considered proinflammatory, causing cell and tissue destruction. Recent findings have challenged this inflammatory role of ROS, and today, ROS are also known to regulate immune responses and cell proliferation and to determine T-cell autoreactivity. NOX2-derived ROS have been shown to suppress antigen-dependent T-cell reactivity and remarkably to reduce the severity of experimental arthritis in both rats and mice. In this review, we discuss the role of ROS and the NOX2 complex as suppressors of autoimmunity, inflammation, and arthritis. Antioxid. Redox Signal. 15, 2197–2208.

1 December 2014 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
Tiina KelkkaTiina Kelkka
Tiina Kelkka
DKDeborah Kienhöfer
Deborah Kienhöfer
MHMarkus Hoffmann
Markus Hoffmann
MLMarjo Linja
Marjo Linja
KWKajsa Wing
Kajsa Wing
Rikard HolmdahlRikard Holmdahl
Rikard Holmdahl
Aims: Chronic granulomatous disease (CGD) is a primary immunodeficiency caused by mutations in the phagocyte reactive oxygen species (ROS)–producing NOX2 enzyme complex and characterized by recurrent infections associated with hyperinflammatory and autoimmune manifestations. A translational, comparative analysis of CGD patients and the corresponding ROS-deficient Ncf1 m1J mutated mouse model was performed to reveal the molecular pathways operating in NOX2 complex deficient inflammation. Results: A prominent type I interferon (IFN) response signature that was accompanied by elevated autoantibody levels was identified in both mice and humans lacking functional NOX2 complex. To further underline the systemic lupus erythematosus (SLE)-related autoimmune process, we show that naïve Ncf1 m1J mutated mice, similar to SLE patients, suffer from inflammatory kidney disease with IgG and C3 deposits in the glomeruli. Expression analysis of germ-free Ncf1 m1J mutated mice reproduced the type I IFN signature, enabling us to conclude that the upregulated signaling pathway is of endogenous origin. Innovation: Our findings link the previously unexplained connection between ROS deficiency and increased susceptibility to autoimmunity by the discovery that activation of IFN signaling is a major pathway downstream of a deficient NOX2 complex in both mice and humans. Conclusion: We conclude that the lack of phagocyte-derived oxidative burst is associated with spontaneous autoimmunity and linked with type I IFN signature in both mice and humans. Antioxid. Redox Signal . 21, 2231–2245.

19 December 2015 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
Rikard HolmdahlRikard Holmdahl
Rikard Holmdahl
OSOuti Sareila
Outi Sareila
LOLina M. Olsson
Lina M. Olsson
LBLiselotte Bäckdahl
Liselotte Bäckdahl
KWKajsa Wing
Kajsa Wing

1 September 2011 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Juri Mikael TimonenJuri Mikael Timonen
Juri Mikael Timonen
RNRiina M. Nieminen
Riina M. Nieminen
OSOuti Sareila
Outi Sareila
AGAntonis Goulas
Antonis Goulas
LMLauri J. Moilanen
Lauri J. Moilanen
PAPaula H. Aulaskari
Paula H. Aulaskari

27 December 2012 in Journal of Leukocyte Biology
Verified
Journal Article
Open access
PDF file
OSOuti Sareila
Outi Sareila
NJNoora Jaakkola
Noora Jaakkola
POPeter Olofsson
Peter Olofsson
Tiina KelkkaTiina Kelkka
Tiina Kelkka
Rikard HolmdahlRikard Holmdahl
Rikard Holmdahl
The p47phox (NCF1) variant expressed in Ncf1m1J mice is defective in activating the NOX2 complex to produce ROS. A point mutation in the mouse Ncf1m1J gene decreases production of ROS by the phagocytic NOX2 complex. Three mRNA splice variants are expressed, but only one is expressed as a protein, although at lower levels than the WT NCF1 (also known as p47phox). Our aim was to investigate whether the mutant p47phox, lacking 8 aa, is active, but as a result of its low expression, ROS production is decreased in Ncf1m1J mice, or whether the mutant p47phox completely lacks the capability to activate the NOX2 complex. The p47phox mutant (Δ228–235), which was equal to the protein in Ncf1m1J mice, failed to activate the NOX2 complex. When the deleted region was narrowed down to 2 aa, the p47phox protein remained inactive and failed to translocate to the membrane upon activation. Single amino acid substitutions revealed Thr233 to be vital for ROS production. Residues Tyr231 and Val232 also seemed to be important for p47phox function, as p47phox_Y231G and p47phox_V232G resulted in a >50% decrease in ROS production by the NOX2 complex. In addition, we identified the epitope of the D-10 anti-p47phox mAb. In conclusion, the p47phox protein variant expressed in Ncf1m1J mice is completely defective in activating the NOX2 complex to produce ROS, and the effect is dependent on SH3 region amino acids at positions 231–233, which are vital for the proper assembly of the NOX2 complex.

1 April 2006 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
TSTiina Salonen
Tiina Salonen
OSOuti Sareila
Outi Sareila
UJUlla Jalonen
Ulla Jalonen
HKHannu Kankaanranta
Hannu Kankaanranta
RTRaimo Tuominen
Raimo Tuominen
EMEeva Moilanen
Eeva Moilanen
Proinflammatory cytokines and bacterial products trigger inducible nitric oxide synthase (iNOS) expression and nitric oxide (NO) production in inflammatory and tissue cells. In inflammation, NO acts as an important mediator having both proinflammatory and destructive effects. Protein kinase C (PKC) is a family of serine–threonine protein kinase isoenzymes involved in signal transduction pathways related to inflammatory responses. The aim of the present study was to investigate the role of classical PKC (cPKC) isoenzymes in the regulation of iNOS expression and NO production in murine J774 macrophages and the mechanisms involved. RO318220 (inhibits PKCβ, PKCγ and PKCɛ), GÖ6976 (inhibits cPKC isoenzymes PKCα and PKCβ) and LY333531 (inhibits PKCβ) reduced lipopolysaccharide (LPS)‐induced NO production and iNOS expression in a dose‐dependent manner as did 6 h pretreatment with 1 μM phorbol 12‐myristate 13‐acetate (PMA) (which was shown to downregulate PKC expression). PKC inhibitors also reduced LPS‐induced iNOS mRNA levels, but they did not affect the half‐life of iNOS mRNA. PKC inhibitors did not alter LPS‐induced activation of NF‐κB as measured by electrophoretic mobility shift assay. All PKC inhibitors used and pretreatment with 1 μM PMA inhibited signal transducer and activator of transcription 1 (STAT1) activation as measured by the translocation of STAT1α from the cytosol to the nucleus by Western blot. In addition, inhibition of STAT1 activation by AG‐490, an inhibitor of JAK‐2, also reduced NO production. These results suggest that cPKC isoenzymes, especially PKCβ, mediate the upregulation of iNOS expression and NO production in activated macrophages in an NF‐κB‐independent manner, possibly through the activation of transcription factor STAT1. British Journal of Pharmacology (2006) 147, 790–799. doi:10.1038/sj.bjp.0706672